Michael Swit, profile picture

Michael Swit

Sort by
FDA Regulation of Promotion & Advertising -- Part 8: Handling Promotional Compliance at the Company Level
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 6: First Amendment, Off-Label and False Claims; Guidance on Medical Product Communications Consistent with Labeling
FDA Regulation of Promotion & Advertising -- Part 5: Social Media & Internet
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement – Actions, Powers, & Consequences
FDA Regulation of Promotion & Advertising -- Part 3: Disseminating Scientific Information
FDA Regulation of Promotion & Advertising --Part 2: Direct-to-Consumer Ads
FDA Regulation of Promotion & Advertising -- Part 1: The Basics
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for Start-Ups
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Successful Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
FDA Inspections: Handling the Administrative and Legal Consequences -- Understanding How Ugly It Can Get
FDA Regulation of Advertising of Diagnostics, RUO Products, and Laboratory Developed Tests
Basics of FDA Regulation of Device & IVD Advertising
Presentation on Critical Legal Issues Facing GMP Compliance